Janus Henderson Group PLC Acquires 45,199 Shares of Teleflex Incorporated $TFX

Janus Henderson Group PLC lifted its stake in Teleflex Incorporated (NYSE:TFX) by 1.1% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,291,311 shares of the medical technology company’s stock after purchasing an additional 45,199 shares during the period. Janus Henderson Group PLC owned 0.10% of Teleflex worth $513,281,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of the stock. AQR Capital Management LLC lifted its position in Teleflex by 478.1% during the third quarter. AQR Capital Management LLC now owns 2,366,131 shares of the medical technology company’s stock valued at $287,603,000 after purchasing an additional 1,956,811 shares in the last quarter. State Street Corp increased its position in Teleflex by 1.5% in the fourth quarter. State Street Corp now owns 1,478,776 shares of the medical technology company’s stock worth $180,470,000 after buying an additional 22,111 shares in the last quarter. Dimensional Fund Advisors LP increased its position in Teleflex by 0.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,250,665 shares of the medical technology company’s stock worth $152,630,000 after buying an additional 5,051 shares in the last quarter. Geode Capital Management LLC raised its stake in shares of Teleflex by 10.6% in the fourth quarter. Geode Capital Management LLC now owns 985,684 shares of the medical technology company’s stock worth $120,312,000 after buying an additional 94,679 shares during the period. Finally, Abrams Bison Investments LLC raised its stake in shares of Teleflex by 5.6% in the fourth quarter. Abrams Bison Investments LLC now owns 969,000 shares of the medical technology company’s stock worth $118,257,000 after buying an additional 51,075 shares during the period. 95.62% of the stock is owned by institutional investors.

Teleflex Stock Performance

NYSE TFX opened at $134.50 on Thursday. The firm has a market cap of $5.95 billion, a price-to-earnings ratio of -5.90, a price-to-earnings-growth ratio of 1.00 and a beta of 0.82. The company has a quick ratio of 2.03, a current ratio of 2.55 and a debt-to-equity ratio of 0.82. The business has a 50-day moving average price of $130.87 and a 200-day moving average price of $121.12. Teleflex Incorporated has a twelve month low of $100.18 and a twelve month high of $139.67.

Teleflex (NYSE:TFX) last issued its earnings results on Thursday, May 7th. The medical technology company reported $1.39 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.21 by $0.18. Teleflex had a positive return on equity of 13.29% and a negative net margin of 35.88%.The company had revenue of $548.30 million for the quarter, compared to the consensus estimate of $536.91 million. During the same quarter last year, the company earned $1.44 EPS. The firm’s quarterly revenue was up 32.3% on a year-over-year basis. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. As a group, equities research analysts predict that Teleflex Incorporated will post 6.7 EPS for the current fiscal year.

Teleflex Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 30th. Stockholders of record on Monday, May 25th were given a dividend of $0.34 per share. The ex-dividend date was Friday, May 22nd. This represents a $1.36 annualized dividend and a dividend yield of 1.0%. Teleflex’s dividend payout ratio (DPR) is presently -5.96%.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on TFX. BMO Capital Markets assumed coverage on Teleflex in a research note on Wednesday, July 8th. They set an “outperform” rating and a $159.00 price objective for the company. Wall Street Zen upgraded shares of Teleflex from a “sell” rating to a “hold” rating in a research note on Saturday, June 27th. Royal Bank Of Canada raised shares of Teleflex from a “sector perform” rating to an “outperform” rating and lifted their price target for the company from $135.00 to $155.00 in a report on Friday, May 8th. Truist Financial reaffirmed a “hold” rating and set a $143.00 price target (up from $135.00) on shares of Teleflex in a report on Monday, May 11th. Finally, Wells Fargo & Company increased their price objective on shares of Teleflex from $130.00 to $138.00 and gave the stock an “equal weight” rating in a research note on Friday, May 8th. One research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Teleflex currently has an average rating of “Hold” and a consensus price target of $147.70.

Teleflex Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.